Related Experiment Video

Updated: Jun 28, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

[Treatment of neonatal hyperbilirubinemia]

M D Carvalho1

  • 1Universidade Federal Fluminense (UFF), Niterói, RJ, Brazil.

Jornal De Pediatria
|December 17, 2003
PubMed

Insights

Neonatal jaundice is common, but advances in phototherapy and medications significantly reduce the need for exchange transfusions in newborns. Pediatricians and neonatologists can effectively manage infant jaundice with current knowledge.

Area of Science:

  • Neonatology
  • Pediatrics
  • Bilirubin Metabolism

Background:

  • Neonatal jaundice, characterized by elevated serum bilirubin, is a prevalent condition in newborns.
  • Effective management is crucial to prevent potential neurotoxicity.

Purpose of the Study:

  • To review recent medical literature on neonatal jaundice treatment.
  • Focus on practical aspects relevant to pediatricians and neonatologists.
  • Evaluate current therapeutic strategies for neonatal hyperbilirubinemia.

Main Methods:

  • Extensive literature review of recent medical studies.
  • Inclusion of authors' clinical experience.
  • Focus on phototherapy, exchange transfusion, and pharmacologic interventions.

Main Results:

  • Significant advancements in neonatal jaundice treatment have been observed.
  • Phototherapy and pharmacologic agents are increasingly utilized.
  • The necessity for exchange transfusion has notably decreased.

Conclusions:

  • Current understanding of phototherapy mechanisms and improved technology enhance its efficacy.
  • Pharmacologic agents that reduce bilirubin production offer a valuable alternative.
  • These advancements collectively minimize the requirement for invasive procedures like exchange transfusion.

More Related Videos

A Swine Model of Neonatal Asphyxia10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...